CSPC Pharmaceutical Group Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
8/10
|
12.72 | 36.59 | -65.23% | 26.26 | -51.56% |
| P/S |
|
2.38 | 7.13 | -66.7% |
|
|
| P/BV |
|
2.13 | 3.66 | -41.64% |
|
|
| P/FCF |
|
30.05 | -11.82 | -354.29% |
|
|
| Ev/Ebitda |
|
7.12 | 2.91 | 144.85% |
|
|
| Ev/S |
|
1.73 | 19.3 | -91.06% |
|
|
| Ev/FCF |
|
23.75 | -7.89 | -401.16% |
|
|
| E/P |
|
0.0855 | 0.0325 | 163.38% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
27.54 | -9.7 | -383.86% | 26.78 | +2.83% |
| ROE |
|
18.53 | 4.42 | 319.29% |
|
|
| ROA |
|
13.34 | 2.95 | 352.38% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
18.68 | -11.15 | -267.56% |
|
|
| ROCE |
|
0 | 0.1527 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0673 | 0.7677 | -91.24% | 0.0629 | +6.9% |
| Nеt Debt/Ebitda |
|
0 | 0.0174 | -100% |
|
|
| Debt/Ratio |
|
0.0126 | 0.1212 | -89.62% |
|
|
| Debt/Equity |
|
0.0531 | 0.8042 | -93.4% |
|
|
| Debt/Net Income |
|
0.0992 | 1.54 | -93.55% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
5.98 | 5.7 | 4.92% | 3.66 | +63.4% |
| Number of years of dividend growth |
|
9 | 1.13 | 700% | ||
| DSI |
|
1 | 0.5838 | 71.29% |
|
|
| Average dividend growth |
|
19.17 | 3.2 | 498.65% |
|
|
| Average percentage for 5 years |
|
3.66 | 4.95 | -26.1% |
|
|
| Average percentage for payments |
|
33.12 | 24.82 | 33.44% |
|
|
| Difference from average difference in sector |
|
0.2802 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
7/10
|
57.23 | 1.85 | 2993.51% | ||
| Growth impulse Ebitda in 5 years |
|
69.45 | -44.43 | -256.31% | ||
| Growth impulse Net Income in 5 years |
|
58.14 | 58.07 | 0.1205% | ||
| Growth impulse FCF in 5 years |
|
37.59 | -7.48 | -602.54% | ||
| Growth impulse EPS in 5 years |
|
54.59 | -198.43 | -127.51% |
IP Score
7.25/10
